Viewing Study NCT01681433


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2025-12-31 @ 3:48 PM
Study NCT ID: NCT01681433
Status: TERMINATED
Last Update Posted: 2022-07-11
First Post: 2012-09-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
Sponsor: Costantine Albany
Organization: